Nova Mentis Life Science Corp. — Form D
Nova Mentis Life Science Corp. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-04. The offering totals $12K, of which $12K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-08-04
- Form: D
- Accession: 0001689231-20-000004
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $12K
- Amount sold: $12K
- Investors: 1
- Date of first sale: 2020-06-23
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-372464
Issuer
- Name: Nova Mentis Life Science Corp.
- CIK: 0001689231
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 700-838 WEST HASTINGS STREET, VANCOUVER, A1, V6C 0A6
- Phone: 7788190244
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Steven Feldman | Director | Lynbrook, NY |
| Dr. Aylia Mohammadi | Director | Vancouver, A1 |
| William Rascan | Director | Vancouver, A1 |
| Kelly Pladson | Executive Officer | VANCOUVER, A1 |
| William Rascan | Executive Officer | Vancouver, A1 |
| Jamie Robinson | Executive Officer | GRAND CAYMAN, E9 |
| KEITH ANDERSON | Director | BOSTON, MA |
| Doug Macdonell | Director | Vancouver, A1 |
Other filings by this issuer (2)
More